Mr Campbell Roxburgh is a honorary consultant colorectal surgeon and Clinical Senior Lecturer at the University of Glasgow. He trained in the West of Scotland before undertaking a post-CCT fellowship in advanced colorectal surgical oncology at Memorial Sloan Kettering Cancer Centre in New York City. Since returning to Scotland in 2016, Campbell has secured a CSO-funded Scottish Senior Clinical Fellowship to support his research into development of novel neoadjuvant strategies incorporating immune oncology-radiotherapy combinations in rectal cancer. He is the chief investigator of the UK phase II PRIME-RT trial evaluating the addition of Durvalumab to extended neoadjuvant strategies in rectal cancer. He plays a leading role in the Scottish National Robotic-Assisted Surgery (RAS) Framework, chairing the National RAS Clinical Reference Group and has led on the implementation of colorectal RAS in Scotland in recent years. His clinical interests include minimally invasive/ robotic cancer surgery, surgery for locally advanced or recurrent disease and organ preservation in rectal cancer. His research interests include clinical and translational cancer research and clinical trials.